Skip to content

Tag

research & development

Pharmacist Only
, ,

Topelia Australia launches US$25M Series A call for COVID-19 ATT Ziverdox

Gold Cross | October 15, 2021
, , ,

Phase 1 clinical trial results show promise for scar healing

Gold Cross | September 13, 2021
, ,

The world is desperate for new antibiotics, and New Zealand’s unique fungi look promising

Gold Cross | September 10, 2021
Pharmacist Only
, ,

Monash University researchers unlock the key that could lead to the development of non-opioid painkillers to treat chronic pain

Gold Cross | September 10, 2021
,

Australian research project investigating long-term impact of COVID-19 awarded 2021 Gilead Fellowship Grant

Gold Cross | July 1, 2021
, ,

Queensland scientists develop peptide-based drugs that could reduce severity of COVID-19

Gold Cross | May 25, 2021

Latest Posts

New STI impacts 1 in 3 women: landmark study reveals men are the missing link
Gold Cross | March 10, 2025
Pharmacist Only
Two weeks until APP2025 brings the pharmacy industry together on the Gold Coast
Gold Cross | March 6, 2025
PATY 2025: Nominations now open!
Gold Cross | March 3, 2025

Featured Posts

GOLD CROSS endorses Team Medical®
Gold Cross | February 18, 2025
College training supports new Australian Government women’s health initiative
Gold Cross | February 10, 2025
Professor Anna Peeters appointed VicHealth CEO
Gold Cross | February 4, 2025

Tags

Scroll To Top